Terms: = Bone cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
127 results:
1. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
[TBL] [Abstract] [Full Text] [Related]
2. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.
Shi P; Lin Z; Song Y; Li Z; Zeng M; Luo L; Cao Y; Zhu X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):159. PubMed ID: 38530432
[TBL] [Abstract] [Full Text] [Related]
3. High expression of BCat1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.
Pan J; Wang Y; Huang S; Mao S; Ling Q; Li C; Li F; Yu M; Huang X; Huang J; Lv Y; Li X; Ye W; Wang H; Wang J; Jin J
J Mol Med (Berl); 2024 Mar; 102(3):415-433. PubMed ID: 38340163
[TBL] [Abstract] [Full Text] [Related]
4. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
[TBL] [Abstract] [Full Text] [Related]
5. Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.
Němčíková P; Brunerová L
Vnitr Lek; 2023; 69(5):312-315. PubMed ID: 37827829
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic capability of 18F-PSMA PET-MRI and pelvic MRI plus bone scan in treatment-naive prostate cancer: a single-center paired validating confirmatory study.
Qiao Z; Wang S; Wang H; He B; Shi Z; Zhou H; Yang Q; Chen X; You Z; Zhao J; Wang H
Int J Surg; 2024 Jan; 110(1):87-94. PubMed ID: 37738021
[TBL] [Abstract] [Full Text] [Related]
7. Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast cancer Patients: Study Protocol of a Randomized Controlled Trial.
Zou X; Chen ZY; Yang YH; Qiao Y; He SJ; Li Q; Chen WL; Zhang XY; Li SY; Sha SY; Hu MH; Zhang XY; Yang MJ; Wang RP; Wu HG; Shi Y; Xue XH; Ji YJ
Integr Cancer Ther; 2023; 22():15347354231188679. PubMed ID: 37565358
[TBL] [Abstract] [Full Text] [Related]
8. Prostate cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
Lubarsky R; Ambinder D; Barnett J; Choudhury M; Saji A; Fishman AI; Fullerton S; Phillips JL
Urology; 2023 Oct; 180():28-34. PubMed ID: 37479145
[TBL] [Abstract] [Full Text] [Related]
9. The FBXO32/ATR/atm axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
[TBL] [Abstract] [Full Text] [Related]
10. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD.
Thompson PA; Keating MJ; Ferrajoli A; Jain N; Peterson CB; Garg N; Wang SA; Jorgensen JL; Kadia TM; Bose P; Pemmaraju N; Short NJ; Wierda WG
Leukemia; 2023 Jul; 37(7):1444-1453. PubMed ID: 37138019
[TBL] [Abstract] [Full Text] [Related]
11. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LateR): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; Kremer LCM; Grootenhuis MA; Maurice-Stam H; Tissing WJE; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJH; Pluijm SMF; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Hoefer I; van den Berg SAA; den Hartogh J; Hoeijmakers JHJ; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Healthy Longev; 2023 Apr; 4(4):e155-e165. PubMed ID: 37003274
[TBL] [Abstract] [Full Text] [Related]
12. Relapsed Childhood Acute Lymphoblastic Leukemia: Experience from a Single Tertiary Center in Thailand.
Chotsampancharoen T; Songthawee N; Chavananon S; Sripornsawan P; McNeil EB
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3517-3522. PubMed ID: 36308378
[TBL] [Abstract] [Full Text] [Related]
13. Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel atm/mTOR pathway regulating oxidative phosphorylation.
Park HJ; Gregory MA; Zaberezhnyy V; Goodspeed A; Jordan CT; Kieft JS; DeGregori J
Elife; 2022 Oct; 11():. PubMed ID: 36259537
[TBL] [Abstract] [Full Text] [Related]
14. Effects of Androgen Deprivation Therapy on Extraocular Muscles, Retrobulbar Orbital Fat, and the Optic Nerve in Patients with Prostate cancer.
Sonmez HK; Sonmez G; Dogan S; Horozoglu F; Demirtas A; Evereklioglu C
Ophthalmic Res; 2023; 66(1):272-280. PubMed ID: 36228576
[TBL] [Abstract] [Full Text] [Related]
15. A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma.
Tang W; Li Y; Zou Z; Cui J; Wang F; Zheng Y; Hou L; Pan L; Xiang B; Chang H; Zhang L; Niu T
Cancer Med; 2023 Feb; 12(3):3054-3067. PubMed ID: 36127626
[TBL] [Abstract] [Full Text] [Related]
16. p53 as a unique target of action of cisplatin in acute leukaemia cells.
Kumar S; Tchounwou PB
J Cell Mol Med; 2022 Sep; 26(17):4727-4739. PubMed ID: 35946055
[TBL] [Abstract] [Full Text] [Related]
17. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
[TBL] [Abstract] [Full Text] [Related]
18. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review.
Alugoju P; Krishna Swamy VKD; Anthikapalli NVA; Tencomnao T
Crit Rev Food Sci Nutr; 2023; 63(31):10709-10774. PubMed ID: 35708049
[TBL] [Abstract] [Full Text] [Related]
19. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu AJ; Kosiorek HE; Ueberroth BE; Jaeger E; Ledet E; Kendi AT; Tzou K; Quevedo F; Choo R; Moore CN; Ho TH; Singh P; Keole SR; Wong WW; Sartor O; Bryce AH
Prostate; 2022 Sep; 82(12):1202-1209. PubMed ID: 35652618
[TBL] [Abstract] [Full Text] [Related]
20. Genotoxicity, oxidative stress and transcriptomic effects of Nitenpyram on human bone marrow mesenchymal stem cells.
Liu W; Li Z; Cui X; Luo F; Zhou C; Zhang J; Xing L
Toxicol Appl Pharmacol; 2022 Jul; 446():116065. PubMed ID: 35568224
[TBL] [Abstract] [Full Text] [Related]
[Next]
